Today: 8 February 2026
Subscribe

Nebius stock drops nearly 9% as tariff scare hits tech — Israel AI supercomputer rollout in focus

Nebius stock drops nearly 9% as tariff scare hits tech — Israel AI supercomputer rollout in focus

Nebius Group N.V. (NBIS.O) shares fell 8.68% to $99.29 Tuesday and slipped further after hours, amid a tech selloff triggered by Trump’s tariff threats over Greenland. Israel’s national AI supercomputer launched using Nebius infrastructure, but broader markets stayed risk-averse as the Dow dropped 1.76%, S&P 500 lost 2.06%, and Nasdaq fell 2.39%.
21 January 2026
···
ASX slides as Trump Greenland tariff threat sparks ‘sell America’ trade — gold hits record

ASX slides as Trump Greenland tariff threat sparks ‘sell America’ trade — gold hits record

The S&P/ASX 200 fell 0.4% by mid-morning Wednesday, led by declines in tech and banks, while miners rose on record gold prices near $4,762 an ounce. U.S. President Trump threatened new tariffs on eight European countries after their troops arrived in Greenland, escalating trade tensions. Lynas Rare Earths jumped on a 43% revenue surge. Rio Tinto reported record quarterly iron ore shipments.
21 January 2026
····
Morgan Stanley stock drops 3.7% after-hours as rate-cap deadline and tariff jitters hit banks

Morgan Stanley stock drops 3.7% after-hours as rate-cap deadline and tariff jitters hit banks

Morgan Stanley shares fell 3.7% to $182.10 Tuesday, tracking a broader drop in U.S. bank stocks after the Trump administration threatened a 10% cap on credit-card interest rates. Trading volume doubled its 50-day average. The S&P 500 lost 2.06%. Morgan Stanley’s board declared a $1.00 quarterly dividend, payable Feb. 13 to shareholders of record Jan. 30.
21 January 2026
··
Bank of America stock slips after $1B employee stock award as credit-card cap deadline bites

Bank of America stock slips after $1B employee stock award as credit-card cap deadline bites

Bank of America shares fell 1.64% to $52.10 Tuesday, then held steady after hours. The bank announced a $1 billion employee stock grant, totaling nearly 19 million shares. Investors weighed the move against uncertainty over a possible 10% federal cap on credit-card interest rates. CEO Brian Moynihan sold and repurchased about 17,900 shares last week, according to SEC filings.
21 January 2026
···
Corvus Pharmaceuticals stock surges 167% on eczema drug data as $150 million offering kicks off

Corvus Pharmaceuticals stock surges 167% on eczema drug data as $150 million offering kicks off

Corvus Pharmaceuticals shares soared over 167% to $21.41 in after-hours trading Tuesday after reporting positive placebo-controlled trial results for its experimental eczema pill. The company launched a $150 million underwritten stock and warrant offering following the data release. Analysts raised price targets. About 84 million shares changed hands.
21 January 2026
··
Lumentum stock jumps 10% as Aletheia lifts target to $500 ahead of Feb. 3 earnings

Lumentum stock jumps 10% as Aletheia lifts target to $500 ahead of Feb. 3 earnings

Lumentum shares rose about 10% Tuesday, closing at $356.83 and holding steady after hours. Aletheia Capital’s Skye Chen raised his price target to $500, citing stronger demand for high-speed data-center lasers. Lumentum reports fiscal Q2 results Feb. 3 after the market closes. The company will also present new laser platforms at SPIE Photonics West this week.
21 January 2026
··
Applied Materials stock price dips despite Needham’s big target hike — here’s what traders watch next

Applied Materials stock price dips despite Needham’s big target hike — here’s what traders watch next

Applied Materials fell 2.7% to $318.23 Tuesday, mirroring a sharp drop in semiconductor stocks and the S&P 500. The decline came despite Needham raising its price target to $390, citing stronger demand. Shares traded between $314.58 and $324.35 on volume of 9.4 million. Investors await earnings from ASML and KLA next week, with Applied’s own report due Feb. 12.
21 January 2026
·
RAPT Therapeutics stock jumps 64% as GSK agrees $2.2 billion takeover at $58 a share

RAPT Therapeutics stock jumps 64% as GSK agrees $2.2 billion takeover at $58 a share

Rapt Therapeutics shares surged 64% to $57.57 in after-hours trading after GSK agreed to acquire the company for $58 a share in cash, valuing Rapt at about $2.2 billion. The deal centers on ozureprubart, a long-acting anti-IgE antibody. GSK plans to launch a tender offer within 10 business days. Closing depends on a majority of Rapt shares being tendered and U.S. antitrust clearance.
21 January 2026
···
Goldman Sachs stock drops after-hours as credit-card cap deadline hits banks; Qatar $25B tie-up in focus

Goldman Sachs stock drops after-hours as credit-card cap deadline hits banks; Qatar $25B tie-up in focus

Goldman Sachs shares fell 1.9% to $943.37 in after-hours trading Tuesday as investors awaited a White House decision on capping credit card interest rates. Bank stocks broadly declined, with JPMorgan down 3.1% and Citigroup off 4.4%. Goldman also announced a new deal with the Qatar Investment Authority to raise up to $25 billion for managed funds and co-investments. RBC Capital raised its price target on Goldman to $1,030.
21 January 2026
····
Coinbase stock drops after hours as bitcoin slides; Armstrong keeps crypto bill push alive in Davos

Coinbase stock drops after hours as bitcoin slides; Armstrong keeps crypto bill push alive in Davos

Coinbase shares fell 5.5% to $227.73 in after-hours trading Tuesday after bitcoin dropped 4.6% to about $88,312. CEO Brian Armstrong, speaking in Davos, said he remains optimistic about U.S. crypto legislation despite recent setbacks. Bermuda announced plans for a fully onchain national economy using Circle and Coinbase infrastructure, drawing regulatory attention.
21 January 2026
·····
Lam Research stock swings on tariff jitters as UBS lifts target ahead of earnings

Lam Research stock swings on tariff jitters as UBS lifts target ahead of earnings

Lam Research shares closed down 0.25% Tuesday, holding near $222 in muted after-hours trading as tariff threats from President Trump pressured tech stocks. UBS raised its price target on Lam to $255, citing strong Q2 prospects. Lam’s earnings report is set for Jan. 28. Applied Materials and KLA fell more sharply, dropping 2.7% and 5.2% respectively.
21 January 2026
····
Eli Lilly stock ticks up after FDA “breakthrough” tag for ovarian cancer drug

Eli Lilly stock ticks up after FDA “breakthrough” tag for ovarian cancer drug

Eli Lilly shares closed up 0.3% at $1,041.29 Tuesday and rose slightly after hours after the FDA granted Breakthrough Therapy status to its ovarian cancer drug candidate, sofetabart mipitecan. The designation targets adults with platinum-resistant ovarian cancer. Analyst Seamus Fernandez maintained a buy rating but trimmed his price target. Abivax’s CEO denied rumors of takeover talks with Lilly.
21 January 2026
·
Bloom Energy stock price swings after-hours as RBC flags Texas data-center permit

Bloom Energy stock price swings after-hours as RBC flags Texas data-center permit

Bloom Energy shares rose 1.5% to $151.75 in after-hours trading Tuesday after RBC reaffirmed its Outperform rating and $143 price target, citing an air-permit filing for a 1.5-gigawatt Texas data center project. Bloom also released a survey showing increased demand for onsite power at data centers. The stock swung between $138.68 and $155.03 during the session.
21 January 2026
···
Salesforce stock (CRM) slides after hours as Trump tariff threat hits tech — what’s next

Salesforce stock (CRM) slides after hours as Trump tariff threat hits tech — what’s next

Salesforce shares fell 3.1% to near $220 in after-hours trading Tuesday, extending an eight-session slide. The drop followed a broad tech selloff after President Trump renewed tariff threats tied to Greenland, sending the Dow down 1.76%. Trading volume for Salesforce hit 13 million shares, well above average. The stock now trades nearly 40% below its January 2025 peak.
21 January 2026
··
1 … 302 303 304 305 306 … 1,640

Stock Market Today

OCBC share price slips into weekend — here’s what to watch before the next SGX session

OCBC share price slips into weekend — here’s what to watch before the next SGX session

8 February 2026
Singapore, Feb 8, 2026, 14:50 SGT — Market closed. Oversea-Chinese Banking Corp (SGX:O39) shares last closed at S$21.23 on Friday, down 22 Singapore cents, or 1.03%, on the day. The stock traded between S$21.15 and S$21.35, with about 6.2 million shares changing hands. (ShareInvestor) The pullback leaves investors heading into the new week with one date circled: OCBC’s full-year 2025 results, due on Feb. 25. The update is set to land with Singapore banks near their recent highs and with traders still sensitive to any shift in dividend tone or capital plans. (OCBC) The results will also be an early
Lynas Rare Earths share price slides after ASX selloff — what to watch before Monday

Lynas Rare Earths share price slides after ASX selloff — what to watch before Monday

8 February 2026
Lynas Rare Earths closed Friday down 3.2% at A$14.27, extending losses after a 7.9% drop Thursday. The S&P/ASX 200 fell 2.0% to 8,708.80, pressuring miners. No new disclosures since Lynas’ January update, when it reported a 43% rise in quarterly sales revenue despite power outages. CEO Amanda Lacaze will retire at the end of the financial year.
ANZ share price: What to watch after Friday’s slide into next week

ANZ share price: What to watch after Friday’s slide into next week

8 February 2026
ANZ shares closed down 1.5% at A$37.01 on Friday as director Graham Hodges prepares to step down Sunday. The stock remains up nearly 20% over the past year. Investors await key updates from major Australian banks next week, with ANZ’s first-quarter trading update set for Feb. 12. The ASX 200 fell 2% Friday amid broader market jitters.
Go toTop